A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers

NCT06204250 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasomotor Symptoms
Adult Healthy Volunteers

Interventions

DRUG: GS1-144
DRUG: Placebo

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.

Collaborators

[object Object]